All Abbvie articles
-
News briefs
AbbVie completes acquisition of Allergan
AbbVie , the U.S. biopharmaceutical group, has completed the acquisition of Allergan , an Irish-domiciled pharmaceutical company, following receipt of regulatory approval from all government authorities required by the transaction agreement. Allergan shareholders will receive 0.8660 AbbVie shares and $120.30 in cash for each share held. Allergan common stock ...
-
News briefs
Abbvie and Allergan enter agreement with FTC
Abbvie and Allergan have entered into a consent decree agreement with the staff of the U.S. Federal Trade Commission (FTC) regarding AbbVie’s acquisition of Allergan. Under the terms of the consent decree, the companies have agreed to divest brazikumab , an investigational inhibitor in the development for autoimmune diseases, to ...
